Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

After all, Pulled Myeloma Drug May Help Treat the Illness.

2.

RML to develop bone marrow transplantation at Lady Hardinge Medical College in Safdarjung

3.

Stem Cell Transplant Associated With Better PFS in NKTCL

4.

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

5.

A Chemo-Free Option for Some Advanced Endometrial Cancers?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot